The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
Turning cold tonight with lighter winds and clear spells allowing a patchy frost to develop.
The Welsh Mountain Zoo in Colwyn Bay is crowdfunding to help raise funds for a new home for its snow leopards, as part of a new project.
Basil the collie cross managed to get himself trapped on a ledge at Swansea quarry when a 4.4 magnitude earthquake hit.